Background: Elevated plasma von Willebrand factor antigen (vWF) has been shown to indicate
| INTRODUCTION
Cirrhosis accounts for 1.8% of all deaths in Europe. 1 Portal hypertension drives the development of most complications of cirrhosis. 2, 3 If portal pressure assessed with hepatic venous pressure gradient (HVPG) measurement rises to ≥ 10 mm Hg, indicating the presence of clinically significant portal hypertension (CSPH), patients are at risk for the development of hepatic decompensation. 2 Von Willebrand factor antigen (vWF) is a multimeric adhesive protein released by activated endothelial cells responsible for the interaction between the subendothelium at sites of vascular injury and platelets. Interestingly, vWF levels are commonly elevated in patients with cirrhosis [4] [5] [6] [7] [8] [9] and considered to be a marker of endothelial dysfunction, [4] [5] [6] which contributes to increased intrahepatic resistance and aggravates portal hypertension. Previous studies established its value as a non-invasive marker for CSPH, and thus, predictor of hepatic decompensation and mortality. 7, 9 Moreover, vWF levels predicted the development of complications and mortality independently of HVPG in a small cohort of patients with severe portal hypertension (HVPG ≥ 12 mm Hg), 6 suggesting that vWF levels may not only serve as a surrogate of portal hypertension.
Ferro et al 4 observed that vWF levels correlate with serum levels of endotoxins/lipopolysaccharides (LPS) which are recognised by toll-like receptor 4 (TLR4) on liver sinusoidal endothelial cells (LSEC), and thus, contribute to endothelial dysfunction. In patients with cirrhosis, endotoxemia is mostly a consequence of pathological bacterial translocation from the gut due to impaired intestinal permeability. 10 Importantly, Ferro and co-workers 4 did not assess the severity of portal hypertension, which might itself promote endotoxemia via increasing intestinal permeability. 10 Bacterial translocation can also be quantified by assessing the host's response to pathogen-associated molecular patterns (PAMPs). 10, 11 Previous studies assessed interleukin 6 (IL-6) and LPS-binding protein (LBP), which is an acute phase protein synthesised in response to circulating endotoxins/LPS. 10 Furthermore, C-reactive protein (CRP) has also been shown to be of prognostic value in patients with cirrhosis, [12] [13] [14] even in the absence of active bacterial infections.
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In addition to its potential role as a marker of endothelial perturbation and bacterial translocation, the physiological function of vWF warrants further consideration. In patients with cirrhosis, thrombocytopenia seems to be partly compensated by an increase in vWF levels, which is considered to be a prohemostatic alteration in these patients. 15, 16 Similarly, factor VIII, a potent procoagulant involved in thrombin generation, increases with liver disease severity, while protein C, one of the strongest naturally occurring anticoagulant factors, decreases. 17, 18 The imbalance of these factors, which can be expressed as a ratio, reflects a procoagulant state in patients with cirrhosis and has been shown to predict hepatic decompensation and mortality, independently of liver function. 9 Thus, the prohemostatic properties of vWF as well as the potential association between vWF levels and procoagulant imbalance might further contribute to its predictive value for complications of cirrhosis and mortality. In order to investigate pathophysiological mechanisms contributing to high vWF levels in patients with CSPH, we further assessed IL-6, LBP and vWF/protein C ratio in a subgroup of 131 patients.
| HVPG measurements
The Vienna Hepatic Hemodynamic Lab at the Medical University of Vienna performed the HVPG measurements in accordance with a standardised operating procedure. 19 HVPG measurements were performed in the absence of nonselective beta blockers and nitrates. 
| Laboratory tests
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A P value ≤ 0.05 was considered statistically significant. 3 | RESULTS
| Ethics
| Patient characteristics
Thirty-two per cent of patients had Child-Turcotte-Pugh score (CTP) stage A, while 42% and 26% of patients had CTP score stage B and C cirrhosis respectively. The median HVPG was 19 (7) mm Hg and T A B L E 1 Patient characteristics at the time of HVPG measurement and comparison between patients with low ( ≤ 367%) and high ( > 367%) vWF levels, which was the optimal cut-off for transplant-free mortality, as determined by Youden's index 
| Comparison between patients with low ( ≤ 367%) and high ( > 367%) vWF levels
One hundred and thirty-six patients had vWF levels ≤ 367%, while 89 showed values > 367%, which was the optimal cut-off for transplant-free mortality, as determined by Youden's index. Patients with high vWF levels had more pronounced portal hypertension (21 (7) 
| DISCUSSION
In addition to its physiological function, vWF is a marker of endothelial perturbation in patients with cirrhosis. [23] [24] [25] [26] Altogether, these mechanisms increase intrahepatic resistance, a key component of portal hypertension. 23 Thus, LSEC dysfunction might by itself promote liver disease progression, even beyond the initiation of liver fibrosis/portal hypertension (ie in patients who have already developed CSPH). Together with other potential mechanisms discussed below, this might explain the excellent prognostic value of vWF levels for complications of cirrhosis and mortality.
Endotoxemia due to pathological bacterial translocation is a major driver of LSEC dysfunction in patients with cirrhosis. 4, 27 Interestingly, the association between LBP, as a marker of bacterial translocation, and vWF levels, as a marker of endothelial dysfunction, was independent of HVPG. This underlines the relevance of other mechanisms for bacterial translocation than impaired intestinal permeability due to portal hypertension, 10 such as alterations in gut microbiota and impaired immune function. 28, 29 Intriguingly, endothelial (dys)function might also critically determine the recently identified gut vascular barrier, which controls the dissemination of bacteria from the gut into the liver and the systemic circulation. 30 In analogy to LBP, the correlation between vWF and IL-6 was independent of HVPG. As a response to PAMP-induced TLR4 signalling, IL-6
and other proinflammatory cytokines are produced within the liver by Kupffer cells and propagate HSC activation, with important implications on disease progression. 25, 31 In addition to other bacterial infections (4% increase in risk per 10% vWF), vWF levels predicted the development of spontaneous bacterial peritonitis (SBP; 9% increase in risk per 10% of vWF) on a trend-wise level. SBP is the most common bacterial infection in patients with cirrhosis and ascites and associated with high mortality. 32, 33 This finding is not surprising, as bacterial translocation from the gut is considered as the most important cause of SBP.
We also assessed CRP as a marker of inflammation, as it is a routine laboratory test with wide availability. However, CRP only showed a weak correlation with vWF levels, which did not attain statistical significance after adjusting for HVPG. Interestingly, besides age and vWF levels, only CRP remained in the final model for transplant-free mortality. An increase of 10 mg 9 L À1 was associated with 53% increase in transplant-free mortality risk. Our findings are in line with a series of recent studies demonstrating that CRP has profound prognostic implications in patients with cirrhosis.
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We also observed an independent association between vWF levels and factor VIII/protein C ratio, which is considered as a measure of procoagulant imbalance in patients with cirrhosis 17, 18, 34 and predicted the development of complications (ie new-onset ascites and variceal bleeding) and mortality in a recent study which did not report information on the severity of portal hypertension. 9 The link between vWF levels and procoagulant imbalance, as well as the prohemostatic properties of vWF itself might be of relevance, as hepatic microthrombi can lead to parenchymal extinction and might promote the progression of portal hypertension. Similarly, we observed an independent association between vWF levels and requirement of paracentesis (5% increases in risk per 10% vWF). In contrast, although vWF levels were linked to the development of grade 3/4 HE in univariate analysis, they were not independently predictive in multivariate analysis. This might be explained by the complex pathogenesis of HE, with bacterial translocationinduced inflammation being only a small part of the puzzle. 35 We used a Fine and Gray competing risk regression model 22 Given that the HVPG-independent associations of vWF levels with central pathophysiological mechanisms promoting liver disease progression are confirmed by prospective studies, it should also be investigated whether vWF levels facilitate patient selection for individualised therapy 23 : Since it is a marker of LSEC dysfunction, high vWF levels could identify patients benefiting from statins, 36-42 a promising emerging treatment for portal hypertension. Considering its association with bacterial translocation and SBP, vWF levels may also be of value for guiding antibiotic primary prophylaxis in patients with ascites. 43 Finally, as a potential indicator of procoagulant imbalance, anticoagulation could be of particular benefit in patients with high vWF levels. 44 The main limitation of this study is its retrospective design; however, patients were prospectively characterised at the time of HVPG measurement. Nevertheless, before applying vWF levels for prognostication or investigating its utility for precision medicine, our findings have to be validated by prospective studies. Moreover, we only assessed the ratio between a procoagulant and an anticoagulant (factor VIII/protein C ratio) as a measure of procoagulant imbalance and did not perform thrombin-generation assays in the presence/absence of thrombomodulin or Protac. 17, 18, 34 However, previous studies have repeatedly observed a good correlation between these parameters in patients with cirrhosis. 18, 34 In summary, our results demonstrate that vWF levels are not only a marker of portal hypertension but also independently linked to bacterial translocation, inflammation and procoagulant imbalance. 
